• Spyre Therapeutics (NASDAQ:SYRE) Given "Outperform" Rating at Wedbush

    Source: Buzz FX / 13 Jan 2025 17:30:16   America/Chicago


    Spyre Therapeutics (NASDAQ:SYRE) Given "Outperform" Rating at Wedbush Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Spyre Therapeutics ( NASDAQ:SYRE - Get Free Report ) 's stock had its "outperform" rating restated
    Read more...
Share on,